Skip to main content

European network for investigating the global mechanims of muscle abnormalities in patients with chronic obstructive pulmonary disease

Objective

Chronic Obstructive Pulmonary Disease (COPD) is a common cause of disability among elder EU citizens. An important factor compounding disability in COPD is dysfunction of skeletal muscle (both respiratory and locomotor). ENIGMA unites teams working on physiological, metabolic and structural mechanisms of muscle dysfunction in COPD to give a pan-European approach to the causes and treatment of this problem. The proposal encompasses cross- sectional studies as well as study of the pathophysiological mechanisms underlying existing therapies in COPD. In addition, although the work is mainly to be conducted in humans there is some animal work which paves the way for a pilot study of a novel therapeutic agent in man. A second new treatment approach, which does not involve a pharmacologic agent, is also evaluated.

Funding Scheme

CSC - Cost-sharing contracts

Coordinator

INSTITUTE OF TUBERCOLOSIS AND LUNG DISEASES
Address
Plocka, 26
01-138 Warsaw
Poland

Participants (2)

OSAKJDETZA SERVICIO VASCO DE SALUD
Spain
Address
Plaza De Cruces S/n
48903 Vizcaya - Baracaldo
THE MAGSTIM COMPANY LIMITED
United Kingdom
Address
Spring Gardens
SA34 O0HR Whitland